What raises concerns are some of the recent reports of serious ADRs associated with GLP-1RAs: (i) Pfizers disclosure of elevated aminotransferases in users of lotiglipron (a novel oral GLP-1RA) is indicative of hepatocellular injury [11]
Your healthcare provider can assess your health status and provide personalized guidance on safe practices
These study findings were presented Saturday in Chicago at ENDO 2026, annual meeting of the Endocrine Society
They also explained to me the process of doing vitamin D shots regularly since I have a vitamin D deficiency
It can also serve as a supportive therapy in cancer treatment by helping to mitigate the side effects of chemotherapy
Research in humans is a bit less impressive Clinical trials in humans A 1981 double-blind study found that chronic insomniac patients found that subjects slept 59% more, shorter sleep latency, and higher sleep efficiency (Schneider 1981) A 1987 double-blind study did not find any statistically significant changes in sleep structure as measured by REM sleep, NREM sleep, or total sleep time (Debellis 1987) A 1992 double-blind study in 14 chronic insomnia patients found higher sleep efficiency and subjectively estimated tiredness decreased to similar levels of healthy subjects in 7 nights of injections (Schneider 1992) There are some limitations to these studies however